Coronavirus Outbreak Update
Latest Updates and FAQs
Read More
Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
5600+
Employees globally
70%
Contributed to almost 70% of FDA approved NMEs from 2015/18
50
Years’ experience
25/25
Work with all top 25 BioPharma companies
18
Facilities globally
Latest from Almac
Partnering to advance human health
Explore our locationsPharmaceutical Development & Manufacturing Services
Pharmaceutical Development & Manufacturing Services
Almac recognizes that you need bespoke solutions to suit your needs. Only we can combine the expertise from our world leading range of specialized drug development services to support you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialization.
Find out more
Diagnostic Services
Diagnostic Services
Almac Diagnostic Services is our stratified medicine business unit, specializing in biomarker driven clinical trials. Our global laboratories, in the UK and US, offer tailored solutions from discovery to commercialization: biomarker discovery, assay development & validation, CDx development & commercialization. Your clinical trial diagnostic partner.
Find out more
Galen – Developing and marketing pharmaceuticals globally
Galen – Developing and marketing pharmaceuticals globally
Galen, part of the Almac Group, is a global pharmaceutical company selling medicines worldwide, and partners with like-minded companies to accomplish this.
Find out more
Almac Discovery
Almac Discovery is an independent, research driven drug discovery company dedicated to the development of novel and innovative therapeutics. Our multidisciplinary team of scientists use cutting edge research techniques to develop First in Class preclinical stage assets. Key research themes include protein homeostasis (specifically focused on deubiquitinase enzymes) and next generation protein drug conjugates.
Find out more